This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

HomeBrowseAboutFAQs
Log In
Sign Up
Healthy

To Demonstrate the Relative Bioavailability of Cefzil 500 mg Cefprozil Tablets Under Fasting Conditions

Sponsored by Sandoz

About this trial

Last updated 8 years ago

Study ID

AA17499

Status

Completed

Type

Interventional

Phase

Phase 1

Placebo

No

Accepting

18-75 Years
20 to 54 Years
All
All

Trial Timing

Ended 21 years ago

What is this trial about?

To demonstrate the relative bioavailability of Cefzil 500 mg Cefprozil tablets under fasting conditions.

What are the participation requirements?

Yes

Inclusion Criteria

- No clinically significant abnormal finding on physical exam, medical history, or clinical laboratory results on screening.

No

Exclusion Criteria

- Positive test results for HIV or hepatitis B or C.

- Treatment for drug or alcohol dependence.